Literature DB >> 22957986

Presence and extent of histological tumour necrosis is an adverse prognostic factor in papillary type 1 but not in papillary type 2 renal cell carcinoma.

Martin Pichler1, Georg C Hutterer, Thomas F Chromecki, Karl Pummer, Sebastian Mannweiler, Richard Zigeuner.   

Abstract

AIMS: To date, only limited information is available on the prognostic significance of the presence and extent of histological tumour necrosis with regard to papillary renal cell carcinoma (RCC) types 1 and 2 subclassification. Thus, the aim of this study was to evaluate the prognostic impact of these pathological features on the clinical outcome in papillary subtypes. METHODS AND
RESULTS: The influence of histological tumour necrosis on the clinical outcome in 177 patients with papillary RCC was evaluated. For papillary subtype 1, the presence of histological tumour necrosis was an independent negative prognostic factor for disease-free survival (P = 0.039), and a greater extent of necrosis (>20%) was significantly associated with both poor disease-free and overall survival (P = 0.033 and P = 0.041, respectively). Regarding papillary subtype 2, neither the presence nor extent of histological tumour necrosis was a statistically significant negative prognostic factor.
CONCLUSION: Our findings suggest that the presence and extent of histological tumour necrosis are independent prognosticators in papillary RCC subtype 1, but not in papillary subtype 2. Thus, previously reported conflicting data regarding the prognostic impact of tumour necrosis in papillary RCC might be explained, in part, by heterogeneous subtypes.
© 2012 Blackwell Publishing Limited.

Entities:  

Mesh:

Year:  2012        PMID: 22957986     DOI: 10.1111/j.1365-2559.2012.04328.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  7 in total

1.  Clinicopathological characteristics and cell cycle proteins as potential prognostic factors in myoepithelial carcinoma of salivary glands.

Authors:  F Passador-Santos; M Grönroos; J Irish; R Gilbert; P Gullane; B Perez-Ordonez; A Mäkitie; I Leivo
Journal:  Virchows Arch       Date:  2015-12-28       Impact factor: 4.064

2.  Prognostic Factors for Renal Cell Carcinoma Subtypes Diagnosed According to the 2016 WHO Renal Tumor Classification: a Study Involving 928 Patients.

Authors:  Levente Kuthi; Alex Jenei; Adrienn Hajdu; István Németh; Zoltán Varga; Zoltán Bajory; László Pajor; Béla Iványi
Journal:  Pathol Oncol Res       Date:  2016-12-28       Impact factor: 3.201

Review 3.  Current Insights into Long Non-Coding RNAs in Renal Cell Carcinoma.

Authors:  Maximilian Seles; Georg C Hutterer; Tobias Kiesslich; Karl Pummer; Ioana Berindan-Neagoe; Samantha Perakis; Daniela Schwarzenbacher; Michael Stotz; Armin Gerger; Martin Pichler
Journal:  Int J Mol Sci       Date:  2016-04-15       Impact factor: 5.923

Review 4.  Current Concepts of Non-Coding RNAs in the Pathogenesis of Non-Clear Cell Renal Cell Carcinoma.

Authors:  Dominik A Barth; Ondrej Slaby; Christiane Klec; Jaroslav Juracek; Rares Drula; George A Calin; Martin Pichler
Journal:  Cancers (Basel)       Date:  2019-10-17       Impact factor: 6.639

5.  Whether histologic subtyping affect the oncological outcomes of patients with papillary renal cell carcinoma: evidence from a systematic review and meta-analysis.

Authors:  Shengwei Xiong; Weijie Zhu; Xinfei Li; Yanfei Yu; Kunlin Yang; Lei Zhang; Yue Mi; Xuesong Li; Liqun Zhou
Journal:  Transl Androl Urol       Date:  2021-08

6.  Mechanisms of coagulative necrosis in malignant epithelial tumors (Review).

Authors:  Rosario A Caruso; Giovanni Branca; Francesco Fedele; Eleonora Irato; Giuseppe Finocchiaro; Antonio Parisi; Antonio Ieni
Journal:  Oncol Lett       Date:  2014-07-11       Impact factor: 2.967

7.  Long Non-Coding RNA PANTR1 is Associated with Poor Prognosis and Influences Angiogenesis and Apoptosis in Clear-Cell Renal Cell Cancer.

Authors:  Maximilian Seles; Georg C Hutterer; Johannes Foßelteder; Marek Svoboda; Margit Resel; Dominik A Barth; Renate Pichler; Thomas Bauernhofer; Richard E Zigeuner; Karl Pummer; Ondrej Slaby; Christiane Klec; Martin Pichler
Journal:  Cancers (Basel)       Date:  2020-05-10       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.